Showing results (211-220 of 224) with videos related to
Sort By:
Pageof 23
BMJ Open|October 23, 2025
Natural history of coronary atherosclerosis based on multimodal imaging and physiological fusion techniques: study protocol and rationale for the NASCENT studyYao Jiang, Zhongwei Sun, Bo Yu, et al.Journal of Hypertension|August 29, 2023
99mTc-HFAPi imaging identifies early myocardial fibrosis in the hypertensive heartBoqia Xie, Lina Li, Mingming Lin, et al.JACC. Cardiovascular Interventions|December 21, 2022
Outcomes of Functionally Complete vs Incomplete Revascularization: Insights From the FAVOR III China TrialRui Zhang, Hao-Yu Wang, Kefei Dou, et al.Chinese Medical Journal|March 3, 2025
Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: A multicenter, randomized, sham-controlled trialYanyan Zhao, Changdong Guan, Yang Wang, et al.The Canadian Journal of Cardiology|April 26, 2024
Effectiveness and Safety of a Novel Intravascular Lithotripsy System for Severe Coronary Calcification: The CALCI-CRACK TrialQiuhe Wang, Wenshuai Ma, Dongwei Zhang, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 10, 2021
Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary interventionLijian Gao, Zhan Gao, Ying Song, et al.JACC. Cardiovascular Interventions|November 20, 2025
Rationales Behind Physiology-Guided Revascularization: Diagnostic Impact of Quantitative Flow Ratio in the FAVOR III China TrialRui Zhang, Hao-Yu Wang, Lei Song, et al.Cardiovascular Research|November 13, 2025
Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusionYuze Zhang, Qiuting Dong, Xiaohui Bian, et al.American Heart Journal|July 18, 2020
China Tongxinluo Study for myocardial protection in patients with Acute Myocardial Infarction (CTS-AMI): Rationale and design of a randomized, double-blind, placebo-controlled, multicenter clinical trialYi Xu, Xiangdong Li, Haitao Zhang, et al.Journal of the American College of Cardiology|June 10, 2026
Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: 5-Year Follow-Up From the FAVOR III China Randomized TrialHan Zhang, Changdong Guan, Zening Jin, et al.Pageof 23